Curaleaf Holdings Inc. has increased its acquisition offer for Canadian cannabis producer Aurora Cannabis by 25%, raising the total value to $5 per Aurora share in a mix of cash and stock. This new offer represents an 86% premium over Aurora's average share price before the initial bid and includes a 33% increase in the cash portion. Despite Aurora's refusal to engage in due diligence, Curaleaf's chairman Boris Jordan urged the company to negotiate, highlighting strong shareholder support for the deal. The combined entity would operate in 17 countries with over $1.5 billion in annual revenue and expects $40 million in annual cost savings, potentially creating a more valuable and efficient cannabis company.
Following Curaleaf's increased offer for Aurora Cannabis, the stock is currently trading at USD 4.48 on Pluang, showing a significant 14.29% rise as of Oct 05, 2026, 21:51 WIB. Aurora's market capitalization stands at $248.02 million, with its price fluctuating between a 52-week low of $2.58 and a high of $6.17. Investors typically hold Aurora shares for about 27 days on the platform.
